Pierre Beaurang Nurix Therapeutics, Inc. (NRIX) insider trading activity

Pierre Beaurang is Chief Business Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 4,330 shares of NRIX, which is worth approximately $85,214. The most recent transaction as insider was on Aug 10, 2021, when has been sold 7,500 shares (Common Stock) at a price of $29.97 per share, resulting in proceeds of $224,775. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.33K

0% 3M change

0% 12M change

Total Value Held $85,214

Pierre Beaurang Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 10 2021	SELL Open market or private sale	$224,775 $29.97 p/Share	7,500 Reduced 63.4%	4,330 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$8,325 $1.11 p/Share	7,500 Added 38.8%	11,830 Common Stock
Jul 12 2021	SELL Open market or private sale	$182,250 $24.3 p/Share	7,500 Reduced 63.4%	4,330 Common Stock
Jul 12 2021	BUY Exercise of conversion of derivative security	$8,325 $1.11 p/Share	7,500 Added 38.8%	11,830 Common Stock
Jun 10 2021	SELL Open market or private sale	$225,150 $30.02 p/Share	7,500 Reduced 63.4%	4,330 Common Stock
Jun 10 2021	BUY Exercise of conversion of derivative security	$8,325 $1.11 p/Share	7,500 Added 38.8%	11,830 Common Stock
May 10 2021	SELL Open market or private sale	$201,525 $26.87 p/Share	7,500 Reduced 63.4%	4,330 Common Stock
May 10 2021	BUY Exercise of conversion of derivative security	$8,325 $1.11 p/Share	7,500 Added 38.8%	11,830 Common Stock
Apr 12 2021	SELL Open market or private sale	$207,900 $27.72 p/Share	7,500 Reduced 63.4%	4,330 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$7,350 $0.98 p/Share	7,500 Added 38.8%	11,830 Common Stock
Mar 25 2021	BUY Exercise of conversion of derivative security	$3,637 $0.84 p/Share	4,330 Added 50.0%	4,330 Common Stock
Mar 08 2021	SELL Open market or private sale	$280,350 $37.38 p/Share	7,500 Reduced 100.0%	0 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	$6,300 $0.84 p/Share	7,500 Added 50.0%	7,500 Common Stock
Feb 18 2021	SELL Open market or private sale	$540,000 $36.0 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	$88,350 $5.89 p/Share	15,000 Added 50.0%	15,000 Common Stock

Pierre Beaurang

Chief Business Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Value

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nurix Therapeutics, Inc.

Track Activities on NRIX

Account